CN115477950A - Negative dielectric anisotropy liquid crystal composition and application thereof - Google Patents

Negative dielectric anisotropy liquid crystal composition and application thereof Download PDF

Info

Publication number
CN115477950A
CN115477950A CN202110599258.8A CN202110599258A CN115477950A CN 115477950 A CN115477950 A CN 115477950A CN 202110599258 A CN202110599258 A CN 202110599258A CN 115477950 A CN115477950 A CN 115477950A
Authority
CN
China
Prior art keywords
compound represented
general formula
liquid crystal
percent
crystal composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110599258.8A
Other languages
Chinese (zh)
Other versions
CN115477950B (en
Inventor
陈卯先
李承贺
刘友然
郭云鹏
任婕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Bayi Space LCD Technology Co Ltd
Original Assignee
Beijing Bayi Space LCD Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Bayi Space LCD Technology Co Ltd filed Critical Beijing Bayi Space LCD Technology Co Ltd
Priority to CN202110599258.8A priority Critical patent/CN115477950B/en
Priority to TW110125387A priority patent/TW202248401A/en
Priority to PCT/CN2021/115375 priority patent/WO2022252416A1/en
Publication of CN115477950A publication Critical patent/CN115477950A/en
Application granted granted Critical
Publication of CN115477950B publication Critical patent/CN115477950B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • C09K19/44Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 containing compounds with benzene rings directly linked
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

The invention relates to a liquid crystal composition, in particular to a nematic phase liquid crystal composition, and more particularly relates to a negative dielectric anisotropy liquid crystal composition and application thereof; the liquid crystal composition provided by the invention has a large splay elastic constant and low rotational viscosity, and can improve the contrast and response speed of a liquid crystal display when being used in the liquid crystal display. The negative dielectric anisotropy liquid crystal composition comprises at least one of compounds represented by a general formula I, at least one of compounds represented by a general formula II, at least one of compounds represented by a general formula III and at least one of compounds represented by a general formula IV.

Description

Negative dielectric anisotropy liquid crystal composition and application thereof
Technical Field
The invention relates to a liquid crystal composition, in particular to a nematic phase liquid crystal composition, and more particularly relates to a negative dielectric anisotropy liquid crystal composition and application thereof; the liquid crystal composition provided by the invention has a large splay elastic constant and low rotational viscosity, and can improve the contrast and response speed of a liquid crystal display when being used in the liquid crystal display.
Background
In recent years, LCD displays have been widely used in various products as the most mainstream displays, and among them, negative LCD displays are widely used in mobile phones, notebook computers, tablet computers, computer monitors, televisions, etc. because of their unique high transmittance characteristics.
At present, the negative liquid crystal display has the main disadvantage of slow response speed, and how to improve the response speed becomes an important subject of the negative liquid crystal display.
Compared with the VA mode, the FFS mode has the advantage of hard screen, and is very suitable for the current mobile phone and notebook computer screens adopting a touch screen mode, but the FFS mode is lower than the VA mode in the aspect of contrast. For the FFS mode, the dark state scattering causes an increase in light leakage, and reduces the Contrast Ratio (CR), and the factors that affect the scattering of the liquid crystal composition, such as the order S and the refractive index ne (extraordinary refractive index), no (ordinary refractive index), and Δ n (optical anisotropy) of the liquid crystal, are affected by the design of the liquid crystal panel, and the refractive index characteristics of the liquid crystal are difficult to adjust, so the improvement of the contrast ratio of the liquid crystal mainly lies in how to improve the order ratio of the liquid crystal composition, the order S of the liquid crystal is mainly related to K11 (splay elastic constant), and the larger K11 is, the larger S is.
In view of this, the invention is particularly proposed.
Disclosure of Invention
The present invention aims to provide a negative dielectric anisotropy liquid crystal composition having a low rotational viscosity and a large splay elastic constant, thereby achieving the object of improving the response speed and contrast of a liquid crystal display.
Specifically, the invention provides the following technical scheme:
the invention provides a negative dielectric anisotropy liquid crystal composition, which comprises at least one of compounds represented by a general formula I, at least one of compounds represented by a general formula II, at least one of compounds represented by a general formula III and at least one of compounds represented by a general formula IV;
Figure BDA0003092318500000011
wherein, in the general formula I, R 1 Represents C 1 ~C 12 Wherein one or more C atoms may be replaced by
Figure BDA0003092318500000021
Figure BDA0003092318500000022
Substitution; r 2 Represents C 2 ~C 12 A linear alkenyl group of (a);
in the general formula II, R 3 、R 4 Each independently represents C 1 ~C 12 Straight chain alkyl of (1), C 1 ~C 12 Linear alkoxy of (5) or C 2 ~C 12 A linear alkenyl group of (a); a. The 1 Represents
Figure BDA0003092318500000023
In the general formula III, R 5 、R 6 Each independently represents C 1 ~C 12 Straight chain alkyl group of (1), C 1 ~C 12 Linear alkoxy of (5) or C 2 ~C 12 A linear alkenyl group of (a); a. The 2 Represents
Figure BDA0003092318500000024
In the general formula IV, R 7 、R 8 Each independently represents C 1 ~C 12 Straight chain alkyl group of (1), C 1 ~C 12 Linear alkoxy of (5) or C 2 ~C 12 A linear alkenyl group of (a); a. The 3 、A 4 Each independently represents
Figure BDA0003092318500000025
The liquid crystal composition is used in a liquid crystal display, and the response speed and the contrast of the liquid crystal display can be effectively improved.
Preferably, the compound represented by formula I is selected from one or more of IA or IB:
Figure BDA0003092318500000026
wherein R is 1 Represents C 1 ~C 7 The linear alkyl group of (1); r is 2 Represents C 3 ~C 7 A linear alkenyl group of (a);
further, the compound represented by the general formula I is selected from one or more of IA 1-IB 5:
Figure BDA0003092318500000027
Figure BDA0003092318500000031
Figure BDA0003092318500000041
further, the compound represented by the general formula I is selected from one or more of IA1, IA2, IA3, IA4, IA11, IA12, IA13, IA14, IA21, IA22, IB1, IB3 and IB 5;
as the best technical scheme, the compound represented by the general formula I is selected from one or more of IA1, IA2, IA11, IA12, IB1 and IB 3.
Preferably, the compound represented by formula II is selected from one or more of IIA or IIB:
Figure BDA0003092318500000051
wherein R is 3 、R 4 Each independently represents C 1 ~C 7 Straight chain alkyl group of (1), C 1 ~C 7 Linear alkoxy of (5) or C 2 ~C 7 A linear alkenyl group of (a);
further, the compound represented by the general formula II is selected from one or more of IIA 1-IIB 20:
Figure BDA0003092318500000052
Figure BDA0003092318500000061
further, the compound represented by the general formula II is selected from one or more of IIA6, IIA8, IIA14, IIB1, IIB3, IIB6, IIB7, IIB8, IIB9, IIB11 and IIB 16;
the compound represented by the general formula II is selected from one or more of the compounds shown in the formulas IIA6, IIA8, IIA14, IIB6, IIB8, IIB11 and IIB 16.
Preferably, the compound represented by formula III is selected from one or more of IIIA or IIIB:
Figure BDA0003092318500000062
wherein R is 5 、R 6 Each independently represents C 1 ~C 7 Straight chain alkyl group of (1), C 1 ~C 7 Linear alkoxy radical of (1) or C 2 ~C 7 The linear alkenyl group of (1);
further, the compound represented by the general formula III is selected from one or more of IIIA1 to IIIB 35:
Figure BDA0003092318500000071
Figure BDA0003092318500000081
Figure BDA0003092318500000091
Figure BDA0003092318500000101
Figure BDA0003092318500000111
Figure BDA0003092318500000121
further, the compound represented by the general formula III is selected from one or more of IIIA1, IIIA2, IIIA9, IIIA12, IIIA15, IIIA16, IIIA17, IIIA18, IIIA19, IIIA20, IIIA23, IIIA33, IIIB15, IIIB16, IIIB17, IIIB18, IIIB19, IIIB20, IIIB23 and IIIB 30;
the compound represented by the general formula III is selected from one or more of IIIA9, IIIA12, IIIA15, IIIA16, IIIA19, IIIB15 and IIIB 16.
Preferably, the compound represented by formula IV is selected from one or more of IVA to IVC:
Figure BDA0003092318500000122
Figure BDA0003092318500000131
wherein R is 7 、R 8 Each independently represents C 1 ~C 7 Straight chain alkyl group of (1), C 1 ~C 7 Linear alkoxy of (5) or C 2 ~C 7 A linear alkenyl group of (a);
further, the compound represented by formula IV is selected from one or more of IVA1 to IVC 32:
Figure BDA0003092318500000132
Figure BDA0003092318500000141
Figure BDA0003092318500000151
further, the compound represented by formula IV is selected from one or more of IVA2, IVA4, IVA5, IVA6, IVA8, IVA10, IVA15, IVA18, IVA20, IVA21, IVB14, IVB18, IVC6, IVC13, IVC23, IVC 28;
in a most preferred embodiment, the compound represented by formula IV is selected from one or more of IVA2, IVA4, IVA6, IVA10, IVC23 and IVC 28.
Preferably, the negative dielectric anisotropic liquid crystal composition further includes at least one of compounds represented by general formula V;
Figure BDA0003092318500000152
wherein R is 9 、R 10 Each independently represents C 1 ~C 12 Straight chain alkyl group of (1), C 1 ~C 12 Linear alkoxy of (5) or C 2 ~C 12 A linear alkenyl group of (a); l is 1 、L 2 、L 3 、L 4 Each independently represents H or F;
further, the compound represented by the general formula V is selected from one or more of VA to VC:
Figure BDA0003092318500000161
wherein R is 9 、R 10 Each independently represents C 1 ~C 7 Straight chain alkyl or C 1 ~C 7 Straight chain alkoxy of (2);
further, the compound represented by the general formula V is selected from one or more of VA 1-VC 30:
Figure BDA0003092318500000162
Figure BDA0003092318500000171
Figure BDA0003092318500000181
as a preferable technical scheme, the compound represented by the general formula V is selected from one or more of VA3, VA7, VA8, VB5, VB6, VB7, VB10, VB12, VB13, VB14, VB15, VB17, VC13, VC15, VC21, VC22 and VC 23.
In a preferred embodiment, the compound represented by formula V is one or more compounds selected from VB5, VB7, VB10, VB12, VB14, VB15, VB17, VC13, VC15, VC21, VC22 and VC 23.
Preferably, the negative dielectric anisotropic liquid crystal composition further comprises at least one of the compounds represented by the general formula VI;
Figure BDA0003092318500000182
wherein R is 11 、R 12 Each independently represents C 1 ~C 12 Straight chain alkyl or C 1 ~C 12 Straight chain alkoxy of (a);
further, the compound represented by the general formula VI is selected from one or more of VIA1 to VIA 16:
Figure BDA0003092318500000183
Figure BDA0003092318500000191
further, the compound represented by the general formula VI is selected from one or more of VIA5, VIA6, VIA7, VIA8 and VIA 10.
Preferably, the negative dielectric anisotropic liquid crystal composition further includes at least one of the compounds represented by the general formula VII;
Figure BDA0003092318500000201
wherein R is 13 、R 14 Each independently represents C 1 ~C 12 Straight chain alkyl group of (1), C 1 ~C 12 Linear alkoxy of (5) or C 2 ~C 12 A linear alkenyl group of (a); a. The 5 Represents trans 1,4-cyclohexyl or 1,4-phenylene;
further, the compound represented by the general formula VII is selected from one or more of VIIA to VIIB:
Figure BDA0003092318500000202
wherein R is 13 、R 14 Each independently represents C 1 ~C 7 Straight chain alkyl group of (1), C 1 ~C 7 Linear alkoxy of (5) or C 2 ~C 7 The linear alkenyl group of (1);
further, the compound represented by the general formula VII is selected from one or more of VIIA1 to VIIB 55:
Figure BDA0003092318500000203
Figure BDA0003092318500000211
Figure BDA0003092318500000221
Figure BDA0003092318500000231
as a best technical scheme, the compound represented by the general formula VII is selected from one or more of formulas VIIA1, VIIA6, VIIA11, VIIA16, VIIA28, VIIA33, VIIA38, VIIA43, VIIB3, VIIB23, VIIB28, VIIB33 and VIIB 38.
The negative dielectric anisotropic liquid crystal composition of the present invention may contain, in addition to the above-mentioned compounds, a conventional antioxidant, ultraviolet absorber, light stabilizer, infrared absorber, or the like.
Preferably, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 3-40% of a compound represented by the general formula I;
(2) 1 to 40% of a compound represented by the general formula II;
(3) 1 to 50% of a compound represented by the general formula III;
(4) 10 to 70% of a compound represented by the general formula IV;
(5) 0 to 60% of compounds represented by general formulas V to VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 5 to 25 percent of compound represented by the general formula I;
(2) 2 to 25% of a compound represented by the general formula II;
(3) 3 to 40 percent of compound represented by a general formula III;
(4) 30 to 60% of a compound represented by the general formula IV;
(5) 0 to 40% of a compound represented by the general formulae V to VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 6 to 20 percent of compound represented by the general formula I;
(2) 3 to 19% of a compound represented by the general formula II;
(3) 4 to 36 percent of compound represented by a general formula III;
(4) 35 to 54% of a compound represented by the general formula IV;
(5) 0 to 34% of compounds represented by general formulas V to VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 5 to 20 percent of compound represented by the general formula I;
(2) 5 to 20 percent of compound represented by a general formula II;
(3) 25 to 40% of a compound represented by the general formula III;
(4) 30 to 55 percent of compound represented by a general formula IV;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 10 to 15 percent of compound represented by the general formula I;
(2) 9 to 15 percent of compound represented by a general formula II;
(3) 29 to 36% of a compound represented by the general formula III;
(4) 35 to 48 percent of compound represented by a general formula IV;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 4 to 25 percent of compound represented by the general formula I;
(2) 2 to 25% of a compound represented by the general formula II;
(3) 3 to 40 percent of compound represented by a general formula III;
(4) 30 to 60% of a compound represented by the general formula IV;
(5) 0 to 25% of a compound represented by the general formula V;
(6) 0 to 25% of a compound represented by the general formula VI;
(7) 0 to 20% of a compound represented by the general formula VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 6 to 20 percent of compound represented by the general formula I;
(2) 3 to 19% of a compound represented by the general formula II;
(3) 4 to 36 percent of compound represented by a general formula III;
(4) 35 to 54% of a compound represented by the general formula IV;
(5) 0 to 21% of a compound represented by the general formula V;
(6) 0 to 21% of a compound represented by the general formula VI;
(7) 0 to 14% of a compound represented by the general formula VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 5 to 25 percent of compound represented by the general formula I;
(2) 2 to 20% of a compound represented by the general formula II;
(3) 8 to 32% of a compound represented by the general formula III;
(4) 32 to 57% of a compound represented by the general formula IV;
(5) 1 to 25% of a compound represented by the general formula V;
(6) 0 to 20% of a compound represented by the general formula VI;
(7) 0 to 10% of a compound represented by the general formula VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 9 to 20 percent of compound represented by the general formula I;
(2) 3 to 15 percent of compound represented by a general formula II;
(3) 12 to 27% of a compound represented by the general formula III;
(4) 37 to 52 percent of compound represented by a general formula IV;
(5) 2 to 21% of a compound represented by the general formula V;
(6) 0 to 17% of a compound represented by the general formula VI;
(7) 0 to 4% of a compound represented by the general formula VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 3 to 25 percent of compound represented by the general formula I;
(2) 3 to 25 percent of compound represented by a general formula II;
(3) 3 to 40 percent of compound represented by a general formula III;
(4) 30 to 60% of a compound represented by the general formula IV;
(5) 0 to 25% of a compound represented by the general formula VI;
(6) 0 to 19% of a compound represented by the general formula VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 4 to 19 percent of compound represented by the general formula I;
(2) 4 to 19% of a compound represented by the general formula II;
(3) 4 to 36 percent of compound represented by a general formula III;
(4) 35 to 54% of a compound represented by the general formula IV;
(5) 0 to 21% of a compound represented by the general formula VI;
(6) 0 to 14% of a compound represented by the general formula VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 5 to 20 percent of compound represented by the general formula I;
(2) 3 to 25 percent of compound represented by a general formula II;
(3) 3 to 25% of a compound represented by the general formula III;
(4) 32 to 60% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 10 to 25 percent of compound represented by a general formula VI;
(7) 0 to 18% of a compound represented by the general formula VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 6 to 15 percent of compound represented by the general formula I;
(2) 4 to 19% of a compound represented by the general formula II;
(3) 4 to 19% of a compound represented by the general formula III;
(4) 37 to 54% of a compound represented by the general formula IV;
(5) 0 to 11% of a compound represented by the general formula V;
(6) 13 to 21% of a compound represented by the general formula VI;
(7) 0 to 14% of a compound represented by the general formula VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 6 to 25 percent of compound represented by the general formula I;
(2) 2 to 20% of a compound represented by the general formula II;
(3) 9 to 40 percent of compound represented by a general formula III;
(4) 30 to 55 percent of compound represented by a general formula IV;
(5) 0 to 25% of a compound represented by the general formula V;
(6) 0 to 5% of a compound represented by the general formula VII;
further, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 10 to 20 percent of compound represented by the general formula I;
(2) 3 to 15 percent of compound represented by a general formula II;
(3) 12 to 36 percent of compound represented by a general formula III;
(4) 35 to 52 percent of compound represented by a general formula IV;
(5) 0 to 21% of a compound represented by the general formula V;
(6) And 0 to 1% of a compound represented by the general formula VII.
The compound represented by the general formula I provided by the invention has large negative dielectric anisotropy and large optical anisotropy, and is very effective for improving the negative dielectric anisotropy and the optical anisotropy of the liquid crystal composition; the compound represented by the general formula II provided by the invention is a two-ring negative dielectric anisotropy liquid crystal compound, and the compound has larger negative dielectric anisotropy and excellent intersolubility; the compound represented by the general formula III provided by the invention is a liquid crystal compound containing tricyclic negative dielectric anisotropy, and the compound has larger negative dielectric anisotropy and high clearing point; the compound represented by the general formula IV provided by the invention is a bicyclic ring neutral compound, and the compound has low rotary viscosity. The invention increases the dielectric anisotropy and the optical anisotropy of the liquid crystal composition through the alkene thiophene monomer represented by the general formula I, and reduces the use of negative monomers; the compound represented by the general formula IV reduces the rotational viscosity of the liquid crystal composition, and further improves the response time of the liquid crystal display.
The method for producing the negative dielectric anisotropy liquid crystal composition of the present invention is not particularly limited, and two or more compounds may be mixed and produced by a conventional method, such as a method of mixing different components at a high temperature and dissolving each other, in which a liquid crystal composition is dissolved and mixed in a solvent for the compounds, and then the solvent is distilled off under reduced pressure; alternatively, the negative dielectric anisotropy liquid crystal composition of the present invention may be prepared by a conventional method, for example, by dissolving the component having a smaller content in the main component having a larger content at a higher temperature, or by dissolving the components in an organic solvent, such as acetone, chloroform or methanol, and then mixing the solutions to remove the solvent.
The negative dielectric anisotropy liquid crystal composition has low rotary viscosity and large elastic constant, and further has low ratio of the rotary viscosity to the elastic constant, and the use of the negative dielectric anisotropy liquid crystal composition in a liquid crystal display can obviously improve the response speed of the liquid crystal display and effectively improve the display effect.
The invention also provides the application of the negative dielectric anisotropy liquid crystal composition in a liquid crystal display.
Detailed Description
The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
Unless otherwise indicated, percentages in the present invention are weight percentages; the temperature unit is centigrade; Δ n represents optical anisotropy (25 ℃); epsilon And ε Respectively represent the parallel and perpendicular dielectric constants (25 ℃,1000 Hz); Δ ε represents the dielectric anisotropy (25 ℃,1000 Hz); γ 1 represents rotational viscosity (mpa.s, 25 ℃); cp represents the clearing point (. Degree. C.) of the liquid crystal composition; k 11 、K 22 、K 33 Respectively represent the splay, twist and bend elastic constants (pN, 25 ℃).
In the following examples, the group structures in the liquid crystal compounds are represented by codes shown in Table 1.
Table 1: radical structure code of liquid crystal compound
Figure BDA0003092318500000251
Figure BDA0003092318500000261
Take the following compound structure as an example:
Figure BDA0003092318500000262
expressed as: e1OSO2V;
Figure BDA0003092318500000263
expressed as: 3CPW02;
in the following examples, the liquid crystal composition was prepared by a thermal dissolution method, comprising the steps of: weighing the liquid crystal compound by a balance according to the weight percentage, wherein the weighing and adding sequence has no specific requirement, generally weighing and mixing the liquid crystal compound in sequence from high melting point to low melting point, heating and stirring at 60-100 ℃ to uniformly melt all the components, filtering, rotatably steaming, and finally packaging to obtain the target sample.
In the following examples, the weight percentages of the components in the liquid crystal composition and the performance parameters of the liquid crystal composition are shown in the following tables.
Example 1
Table 2: weight percentage and performance parameters of each component in liquid crystal composition
Figure BDA0003092318500000271
Example 2
Table 3: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000272
Example 3
Table 4: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000273
Figure BDA0003092318500000281
Example 4
Table 5: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000282
Example 5
Table 6: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000283
Example 6
Table 7: weight percentage and performance parameters of each component in liquid crystal composition
Figure BDA0003092318500000284
Figure BDA0003092318500000291
Example 7
Table 8: weight percentage and performance parameters of each component in liquid crystal composition
Figure BDA0003092318500000292
Example 8
Table 9: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000293
Example 9
Table 10: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000294
Figure BDA0003092318500000301
Example 10
Table 11: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000302
Example 11
Table 12: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000303
Example 12
Table 13: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000304
Figure BDA0003092318500000311
Example 13
Table 14: weight percentage and performance parameters of each component in liquid crystal composition
Figure BDA0003092318500000312
Example 14
Table 15: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000313
Example 15
Table 16: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000321
Example 16
Table 17: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000322
Example 17
Table 18: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000323
Example 18
Table 19: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000331
Example 19
Table 20: weight percentage and performance parameters of each component in liquid crystal composition
Figure BDA0003092318500000332
Example 20
Table 21: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000333
Figure BDA0003092318500000341
Example 21
Table 22: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000342
Comparative example 1
Table 23: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0003092318500000343
The values of the various performance parameters of the liquid crystal compositions obtained in example 8 and in comparative example 1 were compared together, see table 24.
Table 24: comparison of Performance parameters of liquid Crystal compositions
Item △n △ε Cp γ1 K 11 K 22 K 33
Example 8 0.090 -3.1 86 74 17.8 8.9 15.8
Comparative example 1 0.091 -3.1 87 82 17.7 8.9 15.9
By comparison, it can be seen that: example 8 provides a liquid crystal composition having a lower rotational viscosity than comparative example 1; the gamma 1 of example 8 was reduced by about 11% relative to comparative example 1, i.e. used in a liquid crystal display, example 8 can accelerate the response speed by about 11% compared with comparative example 1.
From the above examples, the liquid crystal composition provided by the present invention has low rotational viscosity and large optical anisotropy, and can effectively improve the response speed of the liquid crystal display in the display. Therefore, the liquid crystal composition provided by the invention is suitable for a liquid crystal display device, and can obviously improve the response speed characteristic of the liquid crystal display device.
Although the invention has been described in detail hereinabove by way of general description, specific embodiments and experiments, it will be apparent to those skilled in the art that many modifications and improvements can be made thereto based on the invention. Accordingly, it is intended that all such modifications and alterations be included within the scope of this invention as defined in the appended claims.

Claims (10)

1. A negative dielectric anisotropy liquid crystal composition is characterized by comprising at least one of compounds represented by a general formula I, at least one of compounds represented by a general formula II, at least one of compounds represented by a general formula III and at least one of compounds represented by a general formula IV;
Figure FDA0003092318490000011
wherein, in the general formula I, R 1 Represents C 1 ~C 12 Wherein one or more C atoms may be replaced by
Figure FDA0003092318490000012
Substitution; r 2 Represents C 2 ~C 12 A linear alkenyl group of (a);
in the general formula II, R 3 、R 4 Each independently represents C 1 ~C 12 Straight chain alkyl group of (1), C 1 ~C 12 Linear alkoxy of (5) or C 2 ~C 12 The linear alkenyl group of (1); a. The 1 Represents
Figure FDA0003092318490000013
In the general formula III, R 5 、R 6 Each independently represents C 1 ~C 12 Straight chain alkyl group of (1), C 1 ~C 12 Linear alkoxy radical of (1) or C 2 ~C 12 A linear alkenyl group of (a); a. The 2 Represents
Figure FDA0003092318490000014
In the general formula IV, R 7 、R 8 Each independently represents C 1 ~C 12 Straight chain alkyl group of (1), C 1 ~C 12 Linear alkoxy of (5) or C 2 ~C 12 A linear alkenyl group of (a); a. The 3 、A 4 Each independently represents
Figure FDA0003092318490000015
Figure FDA0003092318490000021
2. The negative dielectric anisotropic liquid crystal composition of claim 1, wherein the compound represented by formula I is one or more compounds selected from IA and IB:
Figure FDA0003092318490000022
wherein R is 1 Represents C 1 ~C 7 The linear alkyl group of (1); r 2 Represents C 3 ~C 7 A linear alkenyl group of (a);
preferably, the compound represented by formula I is selected from one or more of IA1 to IB 5:
Figure FDA0003092318490000023
Figure FDA0003092318490000031
Figure FDA0003092318490000041
more preferably, the compound represented by the general formula I is selected from one or more of IA1, IA2, IA3, IA4, IA11, IA12, IA13, IA14, IA21, IA22, IB1, IB3, IB 5;
most preferably, the compound represented by formula I is selected from one or more of IA1, IA2, IA11, IA12, IB1, IB 3.
3. The negative dielectric anisotropic liquid crystal composition of claim 1, wherein the compound represented by formula II is one or more compounds selected from IIA or IIB:
Figure FDA0003092318490000042
wherein R is 3 、R 4 Each independently represents C 1 ~C 7 Straight chain alkyl group of (1), C 1 ~C 7 Linear alkoxy of (5) or C 2 ~C 7 A linear alkenyl group of (a);
preferably, the compound represented by formula II is selected from one or more of IIA1 to IIB 20:
Figure FDA0003092318490000051
Figure FDA0003092318490000061
more preferably, the compound represented by the general formula II is selected from one or more of IIA6, IIA8, IIA14, IIB1, IIB3, IIB6, IIB7, IIB8, IIB9, IIB11 and IIB 16;
most preferably, the compound represented by formula II is selected from one or more of formulae IIA6, IIA8, IIA14, IIB6, IIB8, IIB11, IIB 16.
4. The negative dielectric anisotropic liquid crystal composition of claim 1, wherein the compound represented by formula III is selected from one or more of IIIA or IIIB:
Figure FDA0003092318490000062
wherein R is 5 、R 6 Each independently represents C 1 ~C 7 Straight chain alkyl group of (1), C 1 ~C 7 Linear alkoxy of (5) or C 2 ~C 7 A linear alkenyl group of (a);
preferably, the compound represented by formula III is selected from one or more of IIIA1 to IIIB 35:
Figure FDA0003092318490000071
Figure FDA0003092318490000081
Figure FDA0003092318490000091
Figure FDA0003092318490000101
Figure FDA0003092318490000111
Figure FDA0003092318490000121
more preferably, the compound represented by the general formula III is selected from one or more of IIIA1, IIIA2, IIIA9, IIIA12, IIIA15, IIIA16, IIIA17, IIIA18, IIIA19, IIIA20, IIIA23, IIIA33, IIIB15, IIIB16, IIIB17, IIIB18, IIIB19, IIIB20, IIIB23, IIIB 30;
most preferably, the compound represented by formula III is selected from one or more of IIIA9, IIIA12, IIIA15, IIIA16, IIIA19, IIIB15, IIIB 16.
5. The negative dielectric anisotropy liquid crystal composition according to claim 1, wherein the compound represented by the general formula IV is selected from one or more of IVA to IVC:
Figure FDA0003092318490000131
wherein R is 7 、R 8 Each independently represents C 1 ~C 7 Straight chain alkyl group of (1), C 1 ~C 7 Linear alkoxy of (5) or C 2 ~C 7 A linear alkenyl group of (a);
preferably, the compound represented by formula IV is selected from one or more of IVA1 to IVC 32:
Figure FDA0003092318490000132
Figure FDA0003092318490000141
Figure FDA0003092318490000151
more preferably, the compound represented by formula IV is selected from one or more of IVA2, IVA4, IVA5, IVA6, IVA8, IVA10, IVA15, IVA18, IVA20, IVA21, IVB14, IVB18, IVC6, IVC13, IVC23, IVC 28;
most preferably, the compound represented by formula IV is selected from one or more of IVA2, IVA4, IVA6, IVA10, IVC23, IVC 28.
6. The negative dielectric anisotropic liquid crystal composition according to any one of claims 1 to 5, further comprising at least one of compounds represented by general formula V;
Figure FDA0003092318490000161
wherein R is 9 、R 10 Each independently represents C 1 ~C 12 Straight chain alkyl group of (1), C 1 ~C 12 Linear alkoxy of (5) or C 2 ~C 12 A linear alkenyl group of (a); l is 1 、L 2 、L 3 、L 4 Each independently represents H or F;
preferably, the compound represented by formula V is selected from one or more of VA to VC:
Figure FDA0003092318490000162
wherein R is 9 、R 10 Each independently represents C 1 ~C 7 Straight chain alkyl or C 1 ~C 7 Straight chain alkoxy of (a);
more preferably, the compound represented by formula V is selected from one or more of VA1 to VC 30:
Figure FDA0003092318490000163
Figure FDA0003092318490000171
Figure FDA0003092318490000181
Figure FDA0003092318490000191
most preferably, the compound represented by formula V is selected from one or more of VA3, VA7, VA8, VB5, VB6, VB7, VB10, VB12, VB13, VB14, VB15, VB17, VC13, VC15, VC21, VC22, VC 23.
7. The negative dielectric anisotropic liquid crystal composition of claim 6, further comprising at least one of compounds represented by general formula VI;
Figure FDA0003092318490000192
wherein R is 11 、R 12 Each independently represents C 1 ~C 12 Straight chain alkyl or C 1 ~C 12 Straight chain alkoxy of (a);
preferably, the compound represented by formula VI is selected from one or more of VIA1 to VIA 16:
Figure FDA0003092318490000193
Figure FDA0003092318490000201
more preferably, the compound represented by formula VI is selected from one or more of VIA5, VIA6, VIA7, VIA8 and VIA 10.
8. The negative dielectric anisotropic liquid crystal composition of claim 7, further comprising at least one of compounds represented by general formula VII;
Figure FDA0003092318490000211
wherein R is 13 、R 14 Each independently represents C 1 ~C 12 Straight chain alkyl group of (1), C 1 ~C 12 Linear alkoxy of (5) or C 2 ~C 12 A linear alkenyl group of (a); a. The 5 Represents trans 1,4-cyclohexyl or 1,4-phenylene;
preferably, the compound represented by formula VII is selected from one or more of VIIA to VIIB:
Figure FDA0003092318490000212
wherein R is 13 、R 14 Each independently represents C 1 ~C 7 Straight chain alkyl group of (1), C 1 ~C 7 Linear alkoxy of (5) or C 2 ~C 7 A linear alkenyl group of (a);
more preferably, the compound represented by formula VII is selected from one or more of group VIIA1 to VIIB 55:
Figure FDA0003092318490000213
Figure FDA0003092318490000221
Figure FDA0003092318490000231
Figure FDA0003092318490000241
most preferably, the compound represented by formula VII is selected from one or more of the formulae VIIA1, VIIA6, VIIA11, VIIA16, VIIA28, VIIA33, VIIA38, VIIA43, VIIB3, VIIB23, VIIB28, VIIB33, VIIB 38.
9. The negative dielectric anisotropic liquid crystal composition of claim 8, comprising the following components in percentage by mass:
(1) 3 to 40 percent of compound represented by the general formula I;
(2) 1 to 40% of a compound represented by the general formula II;
(3) 1 to 50% of a compound represented by the general formula III;
(4) 10 to 70% of a compound represented by the general formula IV;
(5) 0 to 60 percent of compounds represented by general formulas V to VII;
preferably, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 5 to 25 percent of compound represented by the general formula I;
(2) 2 to 25% of a compound represented by the general formula II;
(3) 3 to 40 percent of compound represented by a general formula III;
(4) 30 to 60% of a compound represented by the general formula IV;
(5) 0 to 40% of a compound represented by the general formulae V to VII;
more preferably, the negative dielectric anisotropic liquid crystal composition comprises the following components in percentage by mass:
(1) 6 to 20 percent of compound represented by the general formula I;
(2) 3 to 19% of a compound represented by the general formula II;
(3) 4 to 36 percent of compound represented by a general formula III;
(4) 35 to 54% of a compound represented by the general formula IV;
(5) 0 to 34% of compounds represented by general formulas V to VII;
preferably, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 5 to 20 percent of compound represented by the general formula I;
(2) 5 to 20 percent of compound represented by a general formula II;
(3) 25 to 40% of a compound represented by the general formula III;
(4) 30 to 55 percent of compound represented by a general formula IV;
more preferably, the negative dielectric anisotropic liquid crystal composition comprises the following components in percentage by mass:
(1) 10 to 15 percent of compound represented by the general formula I;
(2) 9 to 15 percent of compound represented by a general formula II;
(3) 29 to 36% of a compound represented by the general formula III;
(4) 35 to 48 percent of compound represented by a general formula IV;
preferably, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 4 to 25 percent of compound represented by the general formula I;
(2) 2 to 25% of a compound represented by the general formula II;
(3) 3 to 40 percent of compound represented by a general formula III;
(4) 30 to 60 percent of compound represented by a general formula IV;
(5) 0 to 25% of a compound represented by the general formula V;
(6) 0 to 25% of a compound represented by the general formula VI;
(7) 0 to 20% of a compound represented by the general formula VII;
more preferably, the negative dielectric anisotropic liquid crystal composition comprises the following components in percentage by mass:
(1) 6 to 20 percent of compound represented by the general formula I;
(2) 3 to 19% of a compound represented by the general formula II;
(3) 4 to 36 percent of compound represented by a general formula III;
(4) 35 to 54% of a compound represented by the general formula IV;
(5) 0 to 21% of a compound represented by the general formula V;
(6) 0 to 21% of a compound represented by the general formula VI;
(7) 0 to 14% of a compound represented by the general formula VII;
preferably, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 5 to 25 percent of compound represented by the general formula I;
(2) 2 to 20% of a compound represented by the general formula II;
(3) 8 to 32% of a compound represented by the general formula III;
(4) 32 to 57% of a compound represented by the general formula IV;
(5) 1 to 25% of a compound represented by the general formula V;
(6) 0 to 20% of a compound represented by the general formula VI;
(7) 0 to 10% of a compound represented by the general formula VII;
more preferably, the negative dielectric anisotropic liquid crystal composition comprises the following components in percentage by mass:
(1) 9 to 20 percent of compound represented by the general formula I;
(2) 3 to 15 percent of compound represented by a general formula II;
(3) 12 to 27% of a compound represented by the general formula III;
(4) 37 to 52% of a compound represented by the general formula IV;
(5) 2 to 21% of a compound represented by the general formula V;
(6) 0 to 17% of a compound represented by the general formula VI;
(7) 0 to 4% of a compound represented by the general formula VII;
preferably, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 3 to 25 percent of compound represented by the general formula I;
(2) 3 to 25 percent of compound represented by a general formula II;
(3) 3 to 40 percent of compound represented by a general formula III;
(4) 30 to 60 percent of compound represented by a general formula IV;
(5) 0 to 25% of a compound represented by the general formula VI;
(6) 0 to 19% of a compound represented by the general formula VII;
more preferably, the negative dielectric anisotropic liquid crystal composition comprises the following components in percentage by mass:
(1) 4 to 19 percent of compound represented by the general formula I;
(2) 4 to 19% of a compound represented by the general formula II;
(3) 4 to 36 percent of compound represented by a general formula III;
(4) 35 to 54% of a compound represented by the general formula IV;
(5) 0 to 21% of a compound represented by the general formula VI;
(6) 0 to 14% of a compound represented by the general formula VII;
preferably, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 5 to 20 percent of compound represented by the general formula I;
(2) 3 to 25 percent of compound represented by a general formula II;
(3) 3 to 25% of a compound represented by the general formula III;
(4) 32 to 60% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 10 to 25% of a compound represented by the general formula VI;
(7) 0 to 18% of a compound represented by the general formula VII;
more preferably, the negative dielectric anisotropic liquid crystal composition comprises the following components in percentage by mass:
(1) 6 to 15 percent of compound represented by the general formula I;
(2) 4 to 19% of a compound represented by the general formula II;
(3) 4 to 19% of a compound represented by the general formula III;
(4) 37 to 54% of a compound represented by the general formula IV;
(5) 0 to 11% of a compound represented by the general formula V;
(6) 13 to 21% of a compound represented by the general formula VI;
(7) 0 to 14% of a compound represented by the general formula VII;
preferably, the negative dielectric anisotropy liquid crystal composition comprises the following components in percentage by mass:
(1) 6 to 25 percent of compound represented by the general formula I;
(2) 2 to 20 percent of compound represented by a general formula II;
(3) 9 to 40 percent of compound represented by a general formula III;
(4) 30 to 55 percent of compound represented by a general formula IV;
(5) 0 to 25% of a compound represented by the general formula V;
(6) 0 to 5% of a compound represented by the general formula VII;
more preferably, the negative dielectric anisotropic liquid crystal composition comprises the following components in percentage by mass:
(1) 10 to 20 percent of compound represented by the general formula I;
(2) 3 to 15 percent of compound represented by a general formula II;
(3) 12 to 36 percent of compound represented by a general formula III;
(4) 35 to 52 percent of compound represented by a general formula IV;
(5) 0 to 21% of a compound represented by the general formula V;
(6) And 0 to 1% of a compound represented by the general formula VII.
10. Use of the negative dielectric anisotropic liquid crystal composition of any one of claims 1 to 9 in a liquid crystal display.
CN202110599258.8A 2021-05-31 2021-05-31 Negative dielectric anisotropy liquid crystal composition and application thereof Active CN115477950B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN202110599258.8A CN115477950B (en) 2021-05-31 2021-05-31 Negative dielectric anisotropy liquid crystal composition and application thereof
TW110125387A TW202248401A (en) 2021-05-31 2021-07-09 Negative dielectric anisotropic liquid crystal composition and use thereof
PCT/CN2021/115375 WO2022252416A1 (en) 2021-05-31 2021-08-30 Negative dielectric anisotropic liquid crystal composition and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110599258.8A CN115477950B (en) 2021-05-31 2021-05-31 Negative dielectric anisotropy liquid crystal composition and application thereof

Publications (2)

Publication Number Publication Date
CN115477950A true CN115477950A (en) 2022-12-16
CN115477950B CN115477950B (en) 2024-06-18

Family

ID=84323787

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110599258.8A Active CN115477950B (en) 2021-05-31 2021-05-31 Negative dielectric anisotropy liquid crystal composition and application thereof

Country Status (3)

Country Link
CN (1) CN115477950B (en)
TW (1) TW202248401A (en)
WO (1) WO2022252416A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114525140A (en) * 2022-02-23 2022-05-24 北京八亿时空液晶科技股份有限公司 Fast response negative liquid crystal composition and application thereof
CN114540043A (en) * 2022-02-23 2022-05-27 北京八亿时空液晶科技股份有限公司 Negative liquid crystal composition containing terphenyl and application thereof
CN117917459A (en) * 2023-04-21 2024-04-23 北京八亿时空液晶科技股份有限公司 Liquid crystal composition containing dibenzothiophene compound and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105131976A (en) * 2014-04-22 2015-12-09 默克专利股份有限公司 Liquid crystalline medium
CN106103652A (en) * 2014-03-17 2016-11-09 默克专利股份有限公司 Liquid crystal media
CN107257839A (en) * 2015-03-13 2017-10-17 默克专利股份有限公司 Liquid crystal media
TW201925435A (en) * 2017-11-30 2019-07-01 日商捷恩智股份有限公司 Compounds having dibenzothiophene ring, liquid crystal composition, and liquid crystal display element
CN113512428A (en) * 2020-04-09 2021-10-19 北京八亿时空液晶科技股份有限公司 Liquid crystal composition with negative dielectric anisotropy and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2937342B1 (en) * 2014-04-22 2016-11-30 Merck Patent GmbH 4,6-difluoro dibenzothiophene derivates
EP3228681B1 (en) * 2016-04-07 2018-11-14 Merck Patent GmbH Liquid-crystalline medium and liquid-crystal display comprising the same
TWI744458B (en) * 2017-02-27 2021-11-01 日商捷恩智股份有限公司 Compound with dibenzofuran ring, liquid crystal composition and liquid crystal display element
CN112480048B (en) * 2019-09-12 2023-08-29 石家庄诚志永华显示材料有限公司 Compound, liquid crystal medium, liquid crystal display element and liquid crystal display

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106103652A (en) * 2014-03-17 2016-11-09 默克专利股份有限公司 Liquid crystal media
CN105131976A (en) * 2014-04-22 2015-12-09 默克专利股份有限公司 Liquid crystalline medium
CN107257839A (en) * 2015-03-13 2017-10-17 默克专利股份有限公司 Liquid crystal media
TW201925435A (en) * 2017-11-30 2019-07-01 日商捷恩智股份有限公司 Compounds having dibenzothiophene ring, liquid crystal composition, and liquid crystal display element
CN113512428A (en) * 2020-04-09 2021-10-19 北京八亿时空液晶科技股份有限公司 Liquid crystal composition with negative dielectric anisotropy and application thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114525140A (en) * 2022-02-23 2022-05-24 北京八亿时空液晶科技股份有限公司 Fast response negative liquid crystal composition and application thereof
CN114540043A (en) * 2022-02-23 2022-05-27 北京八亿时空液晶科技股份有限公司 Negative liquid crystal composition containing terphenyl and application thereof
CN117917459A (en) * 2023-04-21 2024-04-23 北京八亿时空液晶科技股份有限公司 Liquid crystal composition containing dibenzothiophene compound and application thereof
CN117917459B (en) * 2023-04-21 2024-09-20 北京八亿时空液晶科技股份有限公司 Liquid crystal composition containing dibenzothiophene compound and application thereof

Also Published As

Publication number Publication date
WO2022252416A1 (en) 2022-12-08
TW202248401A (en) 2022-12-16
CN115477950B (en) 2024-06-18

Similar Documents

Publication Publication Date Title
CN115477950B (en) Negative dielectric anisotropy liquid crystal composition and application thereof
CN105670649B (en) A kind of liquid-crystal composition and its application with high transmittance
CN109913236B (en) High-transmittance liquid crystal composition containing dioxygen heterocyclic compound and application thereof
CN113072957A (en) Positive liquid crystal composition with high contrast
CN112175629B (en) Terphenyl-containing fast response liquid crystal composition and application thereof
CN114437736A (en) Liquid crystal composition containing terphenyl and application thereof
CN113072956B (en) High-contrast negative liquid crystal composition containing phenprobucol and application thereof
CN113072955B (en) Liquid crystal composition containing methoxy bridge negative liquid crystal compound and having large elastic constant and application thereof
CN113072958A (en) Negative liquid crystal composition with high contrast and application thereof
TWI808519B (en) A liquid crystal composition containing pyran and terphenyl and its application
CN113072961B (en) Liquid crystal composition containing methoxy bridge bond negative liquid crystal compound and application thereof
CN113072953A (en) Negative liquid crystal composition with large elastic constant and application thereof
CN113072960A (en) Liquid crystal composition containing 2-methyl-3, 4, 5 trifluorobenzene structure and application thereof
CN112111283B (en) Liquid crystal composition with quick response and application thereof
CN114806599A (en) Negative liquid crystal composition with large elastic constant and application thereof
CN112300811B (en) Liquid crystal composition and liquid crystal display device
CN112111284B (en) Pyran-containing liquid crystal composition and application thereof
CN113072959A (en) Liquid crystal composition with high elastic constant and containing terphenyl structure and application thereof
CN117917459B (en) Liquid crystal composition containing dibenzothiophene compound and application thereof
CN114395404B (en) Negative liquid crystal composition and application thereof
CN112195030B (en) Liquid crystal composition containing tetrahydropyran and terphenyl and application thereof
CN112111285B (en) Liquid crystal composition with cycloalkyl at tail end and application thereof
CN114540043A (en) Negative liquid crystal composition containing terphenyl and application thereof
CN115960614B (en) Positive liquid crystal composition with high contrast and application thereof
CN112300812B (en) Liquid crystal composition and liquid crystal display device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant